Atlas Trials

Interleukin-6 Antagonists in Critically-ill Covid-19 Patients

Clinical trial NCT05218369 · UNKNOWN

Trial details

NCT number
NCT05218369
Sponsor
University of Pecs
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19Critical Illness
Start date
2022-02-06
Primary completion
2023-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.